Emanuele Palomba

Scopus Publications

Correction: Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative review
Giovanni Scaglione, Nicolò Mastroianni, Alberto Rizzo, Emanuele Palomba, Davide Carcione, et al.
Frontiers in Public Health, 2026
Gastritis and AIDS-related cholangiopathy as an unusual presentation of HIV infection
Fabio Brivio, Alice Covizzi, Davide Bernasconi, Guido Gubertini, Monica Schiavini, et al.
Gastroenterology Report, 2026
Ventilator-Associated Pneumonia Due to ESBL-Producing Escherichia coli Successfully Treated with Cefepime/Enmetazobactam: A European Case Report
Bruno Viaggi, Tommaso Giani, Emanuele Palomba, Andrea Gori, Alberto Farese, et al.
Infectious Diseases and Therapy, 2026
Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative review
Giovanni Scaglione, Nicolò Mastroianni, Alberto Rizzo, Emanuele Palomba, Davide Carcione, et al.
Frontiers in Public Health, 2026
Antimicrobial resistance (AMR) represents an escalating global health threat, demanding diagnostic strategies capable of rapid, accurate, and comprehensive pathogen characterization. Genomic sequencing has transformed our ability to elucidate resistance mechanisms and track their evolution, yet its routine clinical adoption remains limited by cost, workflow constraints, and extended turnaround times. This narrative review examines how artificial intelligence (AI) and machine learning (ML) can enhance and operationalize sequencing-based diagnostics across the clinical microbiology continuum. We summarize current AI applications in whole-genome sequencing for AMR prediction, pan-genome feature extraction, and multicenter model generalizability, including emerging approaches such as federated learning. We then explore AI-driven metagenomic analytics for pathogen detection, resistome profiling, outbreak investigation, and prognostic modeling. Complementary non-genomic technologies, Raman spectroscopy and MALDI-TOF MS, are also evaluated for their potential to deliver rapid resistance profiling when integrated with ML. Finally, we discuss practical barriers, including cost, dataset standardization, interpretability, and regulatory challenges, while outlining future directions toward scalable, explainable, and equitable AI-guided diagnostics. Integrating AI with genomic and rapid phenotypic tools offers a pathway to real-time surveillance, optimized antimicrobial stewardship, and strengthened preparedness against emerging infectious threats.
Microbial signatures and host immune responses associated with the development of ventilator-associated pneumonia among patients with neurological injuries
Leonardo Mancabelli, Emanuele Palomba, Federico Magni, Liliane Chatenoud, Ilaria Olgiati, et al.
Microbiology Spectrum, 2026
Ventilator-associated pneumonia (VAP) remains a leading complication in mechanically ventilated patients, yet the contribution of the respiratory microbiota remains poorly understood. The PULMIVAP study is a multicenter, longitudinal cohort investigation of respiratory microbiota composition and host immune responses in critically ill adults intubated for non-pulmonary conditions. A total of 146 intubated adult patients were enrolled across eight Italian ICUs, forming matched groups of 73 with VAP and 73 without. Oropharyngeal swabs and endotracheal aspirates were collected at intubation and either at VAP diagnosis or at a matched point in controls for a total of 584 biological samples. Metataxonomic analyses revealed substantial temporal shifts in microbial communities across both upper and lower respiratory compartments, with a trend toward reduced microbial richness in patients who developed VAP. Several genera, such as Corynebacterium, were more abundant in no-VAP patients, whereas Escherichia-Shigella and Peptoniphilus were enriched in VAP samples. Cytokine-microbiota correlation analysis suggested a pro-inflammatory signature in VAP patients, with Citrobacter positively associated with IFN-γ and TNF-α, while several commensal genera were inversely correlated with inflammatory mediators. Additionally, taxa associated with VAP correlated with lower PaO 2 /FiO 2 ratios, implicating them in disease severity. Consistently, several bacteria, such as Corynebacterium , appeared to be linked to better respiratory outcomes, suggesting protective or risk-associated microbial profiles. Overall, these findings highlight the complex interplay between microbial communities and mucosal immunity in the pathogenesis of VAP. The identification of condition-associated microbial and immunological signatures may inform future strategies for risk stratification and targeted prevention. IMPORTANCE Ventilator-associated pneumonia (VAP) remains a major complication of mechanical ventilation, yet most microbiome studies have focused on late-stage infection or single airway compartments, limiting insight into early microbial dynamics associated with VAP risk. By longitudinally characterizing upper and lower airway microbiota before and during VAP development, this study provides new insights into microbial and immune patterns associated with susceptibility and disease severity in humans. These findings contribute to the current understanding of VAP pathogenesis by suggesting a role for early airway dysbiosis and local immune responses alongside clinical factors. Remarkably, the identification of taxa associated with risk or protection supports the potential for microbiota-informed monitoring and future risk stratification strategies during mechanical ventilation. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT04849039 .
Activity of imipenem/relebactam against KPC-producing Klebsiella pneumoniae and the possible role of Ompk36 mutation in determining resistance: an Italian retrospective analysis
Emanuele Palomba, Agnese Comelli, Francesca Saluzzo, Federico Di Marco, Elisa Matarazzo, et al.
Annals of Clinical Microbiology and Antimicrobials, 2025
Hospital Acquired Infections Among Solid Organ Transplant Recipients Hospitalized in Intensive Care Unit (2018–2024): A Study of the GiViTI Group
Camilla Genovese, Martina Offer, Marta Colaneri, Francesca Dore, Giorgia Montrucchio, et al.
Transplant Infectious Disease, 2025
Introduction Limited data exist regarding the burden of intensive care unit (ICU)‐acquired infections in the early post‐solid organ transplant (SOT) period, particularly in multidrug resistant organisms‐endemic settings. This study aims at describing the epidemiology, clinical characteristics, and outcomes of patients who developed an ICU‐acquired infection following a SOT procedure in Italy from 2018 to 2024. Methods A multicenter, retrospective study was conducted within the Italian PROSAFE project across 31 ICUs from 2018 to 2024. All adult patients admitted to ICU during the same hospitalization as their organ transplant procedure were included. Bloodstream infections, ventilator associated pneumonia, intra‐abdominal infections, and urinary tract infections occurring more than 48 h after ICU admission were retrieved. Results Among 2210 SOT recipients, 154 (6.9%) developed 193 ICU‐acquired infections. Ventilator associated pneumonia was the most frequent (74, 38.3%), followed by bloodstream infections (56, 29%). Multidrug resistant organisms were identified in 34/87 (39%) isolates with available antibiogram. ICU‐acquired infections were associated with significantly higher intra‐ICU mortality (35/154, 22.4% vs. 49/2056, 2.4%; p < 0.001) and longer ICU stays (24 vs. 4 days; p < 0.001). Patients with infections due to multidrug resistant organisms showed higher mortality and length of stay. Conclusions ICU‐acquired infections occurred in nearly 7% of SOT recipients admitted to ICU following a SOT procedure, with a significant contribute of multidrug resistant organisms. These infections were associated with striking differences in mortality and length of stay. Finally, this study suggested that patients with MDRO infections showed trends toward higher mortality and length of stay.
Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project
Marta Colaneri, Giorgia Montrucchio, Giovanni Scaglione, Gianpaola Monti, Giovanni Tricella, et al.
Clinical Microbiology and Infection, 2025
Exploring Human Use of Monoclonal Antibodies Against Critical Bacteria: A Scoping Review of Clinical Trials
Infectious Diseases and Therapy, 2025
Effectiveness of Vascular Catheter Removal Versus Retention in Non-ICU Patients with CRBSI or CABSI in Retrospective, Single-Center Study
Giovanni De Capitani, Marta Colaneri, Claudia Conflitti, Fabio Borgonovo, Lucia Galli, et al.
Microorganisms, 2025
Catheter-associated bloodstream infections (CABSIs) and catheter-related bloodstream infections (CRBSIs) are significant causes of morbidity and mortality worldwide. The current practice favors the removal of vascular access devices (VADs); however, the evidence on this topic remains inconclusive. This study evaluates the clinical outcomes in terms of in-hospital mortality and catheter retention vs. removal in CABSI and CRBSI cases. A retrospective, observational, single-center study was conducted at Luigi Sacco Hospital, Milan, Italy (May 2021–December 2023), and it analyzed non-ICU adult patients with VADs diagnosed with CRBSIs or CABSIs. Clinical and microbiological data were collected to assess the outcomes based on catheter management. Among 1874 patients with VADs, 147 were included, with 164 VAD infection events (92 CABSIs and 72 CRBSIs). Overall, 35 (23.8%) patients with CABSIs and CRBSIs died. Out of those who retained the catheter 19 (35.8%) patients died, while among removal patients 16 (17%) died (p = 0.018). A Candida spp. isolation was found to be significantly associated with a higher likelihood of catheter removal (p = 0.04). Our findings suggest that, in non-ICU CRBSI and CABSI cases, VAD removal may be associated with improved outcomes when feasible.
Corrigendum: Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units (Frontiers in Microbiology, (2024), 15, (1405390), 10.3389/fmicb.2024.1405390)
Giovanni Scaglione, Matilde Perego, Marta Colaneri, Camilla Genovese, Fabio Brivio, et al.
Frontiers in Microbiology, 2025
Solid organ transplant in recipients with ongoing SARS-CoV-2 infection: A systematic review of case reports and series
Andrea Lombardi, Marta Colaneri, Cecilia Azzarà, Paola Saltini, Giulia Viero, et al.
International Journal of Infectious Diseases, 2024
Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases
Emanuele Palomba, Marta Colaneri, Cecilia Azzarà, Marco Fava, Angelo Maccaro, et al.
Open Forum Infectious Diseases, 2024
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
Andrea Lombardi, Simone Villa, Marta Colaneri, Giovanni Scaglione, Francesca Bai, et al.
Journal of Infection and Public Health, 2024
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties
Andrea Lombardi, Laura Alagna, Emanuele Palomba, Giulia Viero, Anna Tonizzo, et al.
Transplant International, 2024
Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units
Giovanni Scaglione, Matilde Perego, Marta Colaneri, Camilla Genovese, Fabio Brivio, et al.
Frontiers in Microbiology, 2024
Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a prospective cohort of COVID-19 patients: CoV-AP study
Davide Mangioni, Mauro Panigada, Emanuele Palomba, Chiara Bobbio, Liliane Chatenoud, et al.
Critical Care, 2023
Perfusion fluid-related infections in liver transplant recipients: A 5-year, single-center, retrospective study
Andrea Lombardi, Giulia Renisi, Daniele Dondossola, Emanuele Palomba, Luca Del Prete, et al.
Transplant Infectious Disease, 2023
Comparison of multiple definitions for ventilator-associated pneumonia in patients requiring mechanical ventilation for non-pulmonary conditions: preliminary data from PULMIVAP, an Italian multi-centre cohort study
L. Alagna, E. Palomba, L. Chatenoud, R. Massafra, F. Magni, et al.
Journal of Hospital Infection, 2023
Surgical site infections in liver transplantation in the era of multidrug-resistant bacteria
Emilietta BRIGATI, Alessandra BANDERA, Dario CONSONNI, Anna GRANCINI, Umberto MAGGI, et al.
Minerva Surgery, 2023
Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients
Davide Mangioni, Liliane Chatenoud, Jacopo Colombo, Emanuele Palomba, Fernando A. Guerrero, et al.
Emerging Infectious Diseases, 2023
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
Andrea Lombardi, Giulia Viero, Simone Villa, Simona Biscarini, Emanuele Palomba, et al.
Biomedicines, 2023
Exploring post-SEPSIS and post-COVID-19 syndromes: crossovers from pathophysiology to therapeutic approach
Darcy Holmes, Marta Colaneri, Emanuele Palomba, Andrea Gori
Frontiers in Medicine, 2023
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
Giuseppe Ancona, Laura Alagna, Claudia Alteri, Emanuele Palomba, Anna Tonizzo, et al.
Frontiers in Immunology, 2023
The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic
Marta Canuti, Maria Cristina Monti, Chiara Bobbio, Antonio Muscatello, Toussaint Muheberimana, et al.
Frontiers in Medicine, 2023
External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019
Shermarke Hassan, Chava L. Ramspek, Barbara Ferrari, Merel van Diepen, Raffaella Rossio, et al.
European Journal of Internal Medicine, 2022
Nocardia Infections in the Immunocompromised Host: A Case Series and Literature Review
Emanuele Palomba, Arianna Liparoti, Anna Tonizzo, Valeria Castelli, Laura Alagna, et al.
Microorganisms, 2022
Hospital acquired infections in COVID-19 patients in sub intensive care unit: analysis of two waves of admissions
S. Castaldi, P. Perrone, E. Luconi, G. Marano, F. Auxilia, et al.
Acta Biomedica, 2022
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment
Alessandra Bandera, Alessandro Nobili, Mauro Tettamanti, Sergio Harari, Silvano Bosari, et al.
Internal and Emergency Medicine, 2022
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment
Raffaella Rossio, Mauro Tettamanti, Alessandro Nobili, Sergio Harari, Pier Mannuccio Mannucci, et al.
Internal and Emergency Medicine, 2022
Antiviral Treatments for Influenza
Emanuele Palomba, Valeria Castelli, Giulia Renisi, Alessandra Bandera, Andrea Lombardi, et al.
Seminars in Respiratory and Critical Care Medicine, 2021
The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections
Giuseppe Ancona, Laura Alagna, Andrea Lombardi, Emanuele Palomba, Valeria Castelli, et al.
Infection and Immunity, 2021
Immune checkpoint inhibitors in people living with hiv/aids: Facts and controversies
Valeria Castelli, Andrea Lombardi, Emanuele Palomba, Giorgio Bozzi, Riccardo Ungaro, et al.
Cells, 2021
Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia
Emanuele Palomba, Maria Carrabba, Gianluca Zuglian, Laura Alagna, Paola Saltini, et al.
International Journal of Infectious Diseases, 2021
Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature
Emanuele Palomba, Marco Maggioni, Giulia Viero, Davide Mangioni, Rosa Lombardi, et al.
Livers, 2021
Mucormycosis in capa, a possible fungal super-infection
Paola Saltini, Emanuele Palomba, Valeria Castelli, Marco Fava, Laura Alagna, et al.
Journal of Fungi, 2021
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
Giorgio Bozzi, Davide Mangioni, Francesca Minoia, Stefano Aliberti, Giacomo Grasselli, et al.
Journal of Allergy and Clinical Immunology, 2021
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes
Andrea Lombardi, Elena Trombetta, Alessandra Cattaneo, Valeria Castelli, Emanuele Palomba, et al.
Frontiers in Immunology, 2020
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy
A. Lombardi, D. Consonni, M. Carugno, G. Bozzi, D. Mangioni, et al.
Clinical Microbiology and Infection, 2020
Multidrug‐resistant gram‐negative bacteria decolonization in immunocompromised patients: A focus on fecal microbiota transplantation
Laura Alagna, Emanuele Palomba, Davide Mangioni, Giorgio Bozzi, Andrea Lombardi, et al.
International Journal of Molecular Sciences, 2020

RECENT SCHOLAR PUBLICATIONS

Ventilator-Associated Pneumonia Due to ESBL-Producing Escherichia coli Successfully Treated with Cefepime/Enmetazobactam: A European Case Report
B Viaggi, T Giani, E Palomba, A Gori, A Farese, GM Rossolini, M Colaneri
Infectious Diseases and Therapy, 1-8 , 2026
2026
Microbial signatures and host immune responses associated with the development of ventilator-associated pneumonia among patients with neurological injuries
L Mancabelli, E Palomba, F Magni, L Chatenoud, I Olgiati, C Buracchi, ...
Microbiology spectrum 14 (5), e03193-25 , 2026
2026
Correction: Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative review
G Scaglione, N Mastroianni, A Rizzo, E Palomba, D Carcione, SG Rimoldi, ...
Frontiers in Public Health 14, 1824508 , 2026
2026
Epidemiology, resistance patterns, and outcomes of candidemia acquired in Italian intensive care units: insights from the GIVITI network (2020–2024)
G Scaglione, M Colaneri, M Offer, G Montrucchio, C Genovese, B Viaggi, ...
Critical Care , 2026
2026
Gastritis and AIDS-related cholangiopathy as an unusual presentation of HIV infection
F Brivio, A Covizzi, D Bernasconi, G Gubertini, M Schiavini, S Grosso, ...
Gastroenterology Report 14, goag017 , 2026
2026
Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative review
G Scaglione, N Mastroianni, A Rizzo, E Palomba, D Carcione, G Brigante, ...
Frontiers in Public Health 14, 1757161 , 2026
2026
Citations: 3
Integrating artificial intelligence
G Scaglione, N Mastroianni, A Rizzo, E Palomba, D Carcione, G Brigante, ...
2026
Hospital Acquired Infections Among Solid Organ Transplant Recipients Hospitalized in Intensive Care Unit (2018–2024): A Study of the GiViTI Group
C Genovese, M Offer, M Colaneri, F Dore, G Montrucchio, G Scaglione, ...
Transplant Infectious Disease 27 (6), e70120 , 2025
2025
Citations: 3
Exploring human use of monoclonal antibodies against critical bacteria: a scoping review of clinical trials
M Piscaglia, G Scaglione, C Genovese, F Borgonovo, F Brivio, ...
Infectious Diseases and Therapy 14 (8), 1619-1647 , 2025
2025
Citations: 10
Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project
M Colaneri, G Montrucchio, G Scaglione, G Monti, G Tricella, C Genovese, ...
Clinical Microbiology and Infection , 2025
2025
Citations: 13
Effectiveness of vascular catheter removal versus retention in Non-ICU patients with CRBSI or CABSI in Retrospective, Single-Center study
G De Capitani, M Colaneri, C Conflitti, F Borgonovo, L Galli, G Scaglione, ...
Microorganisms 13 (5), 1085 , 2025
2025
Citations: 1
Activity of imipenem/relebactam against KPC-producing Klebsiella pneumoniae and the possible role of Ompk36 mutation in determining resistance: an Italian retrospective analysis
E Palomba, A Comelli, F Saluzzo, F Di Marco, E Matarazzo, NL Re, ...
Annals of Clinical Microbiology and Antimicrobials 24 (1), 23 , 2025
2025
Citations: 8
P01. The IMPACT-VAP study: incidence and mortality of ventilator-associated pneumonia in critically ill patients: results from the PROSAFE project
M Colaneri, G Montrucchio, G Scaglione, M Offer, G Tricella, C Genovese, ...
JAC-Antimicrobial Resistance 7 (Supplement_2), dlaf046. 001 , 2025
2025
Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units (vol 15, 1405390, 2024)
G Scaglione, M Perego, M Colaneri, C Genovese, F Brivio, A Covizzi, ...
FRONTIERS IN MICROBIOLOGY 16 , 2025
2025
Corrigendum: Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units
G Scaglione, M Perego, M Colaneri, C Genovese, F Brivio, A Covizzi, ...
Frontiers in Microbiology 16, 1584655 , 2025
2025
Citations: 2
P-229. Epidemiology of catheter-related bloodstream infections in italian intensive care units: data from the Italian network for the evaluation of ICU interventions
C Genovese, M Perego, G Scaglione, E Palomba, G Giordano, V Breschi, ...
Open Forum Infectious Diseases 12 (Suppl 1), ofae631. 433 , 2025
2025
Citations: 1
Solid organ transplant in recipients with ongoing SARS-CoV-2 infection: a systematic review of case reports and series
A Lombardi, M Colaneri, C Azzarà, P Saltini, G Viero, E Palomba, ...
International Journal of Infectious Diseases 147, 107214 , 2024
2024
Citations: 6
Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units
G Scaglione, M Perego, M Colaneri, C Genovese, F Brivio, A Covizzi, ...
Frontiers in microbiology 15, 1405390 , 2024
2024
Citations: 11
Epidemiology, clinical manifestations, and outcome of mucormycosis in solid organ transplant recipients: a systematic review of reported cases
E Palomba, M Colaneri, C Azzarà, M Fava, A Maccaro, G Renisi, G Viero, ...
Open Forum Infectious Diseases 11 (6), ofae043 , 2024
2024
Citations: 13
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
A Lombardi, S Villa, M Colaneri, G Scaglione, F Bai, B Varisco, V Bono, ...
Journal of Infection and Public Health 17 (3), 467-473 , 2024
2024
Citations: 3

MOST CITED SCHOLAR PUBLICATIONS

Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy
A Lombardi, D Consonni, M Carugno, G Bozzi, D Mangioni, A Muscatello, ...
Clinical microbiology and infection 26 (10), 1413. e9-1413. e13 , 2020
2020
Citations: 157
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
G Ancona, L Alagna, C Alteri, E Palomba, A Tonizzo, A Pastena, ...
Frontiers in immunology 14, 1080043 , 2023
2023
Citations: 125
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
G Bozzi, D Mangioni, F Minoia, S Aliberti, G Grasselli, L Barbetta, ...
Journal of Allergy and Clinical Immunology 147 (2), 561-566. e4 , 2021
2021
Citations: 122
Early phases of COVID-19 are characterized by a reduction in lymphocyte populations and the presence of atypical monocytes
A Lombardi, E Trombetta, A Cattaneo, V Castelli, E Palomba, M Tirone, ...
Frontiers in immunology 11, 560330 , 2020
2020
Citations: 80
Immune checkpoint inhibitors in people living with HIV/AIDS: facts and controversies
V Castelli, A Lombardi, E Palomba, G Bozzi, R Ungaro, L Alagna, ...
Cells 10 (9), 2227 , 2021
2021
Citations: 37
Multidrug-resistant gram-negative bacteria decolonization in immunocompromised patients: a focus on fecal microbiota transplantation
L Alagna, E Palomba, D Mangioni, G Bozzi, A Lombardi, R Ungaro, ...
International Journal of Molecular Sciences 21 (16), 5619 , 2020
2020
Citations: 35
Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia
E Palomba, M Carrabba, G Zuglian, L Alagna, P Saltini, V Fortina, C Hu, ...
International Journal of Infectious Diseases 110, 338-340 , 2021
2021
Citations: 31
Nocardia infections in the immunocompromised host: a case series and literature review
E Palomba, A Liparoti, A Tonizzo, V Castelli, L Alagna, G Bozzi, R Ungaro, ...
Microorganisms 10 (6), 1120 , 2022
2022
Citations: 27
The interplay between gut microbiota and the immune system in liver transplant recipients and its role in infections
G Ancona, L Alagna, A Lombardi, E Palomba, V Castelli, G Renisi, ...
Infection and Immunity 89 (11) , 2021
2021
Citations: 26
Antiviral treatments for influenza
E Palomba, V Castelli, G Renisi, A Bandera, A Lombardi, A Gori
Seminars in Respiratory and Critical Care Medicine 42 (06), 859-872 , 2021
2021
Citations: 21
Multidrug-resistant bacterial colonization and infections in large retrospective cohort of mechanically ventilated COVID-19 patients
D Mangioni, L Chatenoud, J Colombo, E Palomba, FA Guerrero, M Bolis, ...
Emerging infectious diseases 29 (8), 1598 , 2023
2023
Citations: 15
Comparison of multiple definitions for ventilator-associated pneumonia in patients requiring mechanical ventilation for non-pulmonary conditions: preliminary data from PULMIVAP …
L Alagna, E Palomba, L Chatenoud, R Massafra, F Magni, L Mancabelli, ...
Journal of Hospital Infection 140, 90-95 , 2023
2023
Citations: 14
Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project
M Colaneri, G Montrucchio, G Scaglione, G Monti, G Tricella, C Genovese, ...
Clinical Microbiology and Infection , 2025
2025
Citations: 13
Epidemiology, clinical manifestations, and outcome of mucormycosis in solid organ transplant recipients: a systematic review of reported cases
E Palomba, M Colaneri, C Azzarà, M Fava, A Maccaro, G Renisi, G Viero, ...
Open Forum Infectious Diseases 11 (6), ofae043 , 2024
2024
Citations: 13
Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units
G Scaglione, M Perego, M Colaneri, C Genovese, F Brivio, A Covizzi, ...
Frontiers in microbiology 15, 1405390 , 2024
2024
Citations: 11
Exploring human use of monoclonal antibodies against critical bacteria: a scoping review of clinical trials
M Piscaglia, G Scaglione, C Genovese, F Borgonovo, F Brivio, ...
Infectious Diseases and Therapy 14 (8), 1619-1647 , 2025
2025
Citations: 10
New antibiotics against multidrug-resistant Gram-negative bacteria in liver transplantation: clinical perspectives, toxicity, and PK/PD properties
A Lombardi, L Alagna, E Palomba, G Viero, A Tonizzo, D Mangioni, ...
Transplant International 37, 11692 , 2024
2024
Citations: 10
Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a prospective …
D Mangioni, M Panigada, E Palomba, C Bobbio, L Chatenoud, L Alagna, ...
Critical Care 27 (1), 369 , 2023
2023
Citations: 10
Activity of imipenem/relebactam against KPC-producing Klebsiella pneumoniae and the possible role of Ompk36 mutation in determining resistance: an Italian retrospective analysis
E Palomba, A Comelli, F Saluzzo, F Di Marco, E Matarazzo, NL Re, ...
Annals of Clinical Microbiology and Antimicrobials 24 (1), 23 , 2025
2025
Citations: 8
Exploring post-SEPSIS and post-COVID-19 syndromes: crossovers from pathophysiology to therapeutic approach
D Holmes, M Colaneri, E Palomba, A Gori
Frontiers in Medicine 10, 1280951 , 2024
2024
Citations: 8

Emanuele Palomba

EDUCATION

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS